The dendrosomal curcumin study has been published on 5 July 2015 in the European Journal of Pharmacology and now, after passing a short time of its ...

Curcumin Nano drug which can be considered as one of the most prominent achievements of the (Pre) Clinical Cancer Research Group has been welcomed b …

Our Oxytocin study with corresponding role of Dr. Alizadeh (Principal Investigator of PCCRG) achieved to a considerable amount in the online view or …

It’s our great honor that one of our most important articles achieved to more than 300 visits during the past year. Elsevier has reported that our ...

We are pleased to announce that a review article from our 2013 publications has downloaded more than three hundred times

We are proud to announce that two members of the (Pre) Clinical Cancer Research Group (PCCRG) have participated in the national workshop on Cardiac ...

Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.

Based on a study that included more than 1 million women, investigators at NCI have determined that a negative test for HPV infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.

The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, will identify early-stage lung cancer patients with tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those changes can lead to improved survival.